VCU researchers test effectiveness of anti-opioid vaccine The vaccine, developed by the Scripps Research Institute in California, is meant to block the effects of heroin and fentanyl in patients with opioid use disorder. Read more »
Pausing to honor a life “The Pause” — a moment of silence after the death of a patient — recognizes the humanity of the patients and the health care team trying to save them. Read more »
Epilepsy and the social stigma surrounding it November is National Epilepsy Awareness Month, a good time to learn more about the impact the disease has on people’s lives. Read more »
A protein central to immune system function is a new target for treating pulmonary hypertension A protein with a role in sensing cell damage and viral infections is a new target for the treatment of pulmonary hypertension, or increased blood pressure in the lungs. Read more »
Director hired for VCU and VCU Health System’s East End health education and wellness center The center, now known as “VCU Health Hub at 25th,” will be led by Natalie Pennywell, a former state health official. Read more »
Drug reduces tumor recurrence by 50 percent in patients with HER2-positive breast cancer An international clinical trial co-led by a VCU Massey Cancer Center researcher is expected to change the way a specific type of breast cancer is treated in some patients. 12/11/2018
VCU Health genetic counselor: ‘Consider a number of factors’ before buying an at-home genetic testing kit The kits are topping many holiday gift guides, but also come with caution from the clinical genetics community. 12/11/2018
Researchers are testing anti-opioid vaccines. How will they work? Pharmacologist Matthew Banks, who is testing a vaccine against opioid abuse, explains how such a vaccine could affect substance abuse treatment. 12/6/2018
VCU researchers test effectiveness of anti-opioid vaccine Virginia Commonwealth University researchers are testing a vaccine against opioid abuse developed by the Scripps Research Institute in California. The vaccine is meant to block the effects of heroin and fentanyl in patients with opioid use disorder. 12/6/2018
Cherron Gilmore was denied a heart transplant four times. Then she came to VCU Health. A fatal diagnosis after pregnancy and declining health left Gilmore preparing for death. A medical team at Pauley Heart Center saved her life. 12/5/2018
Can liver disease be linked to heart failure? VCU study highlights liver-heart interaction A team of VCU researchers has found that patients with an aggressive type of fatty liver disease are more likely to have limitations in exercise capacity. 11/20/2018
Epilepsy and the social stigma surrounding it November is National Epilepsy Awareness Month, a good time to learn more about the impact the disease has on people’s lives. 11/19/2018
Pausing to honor a life “The Pause” — a moment of silence after the death of a patient — recognizes the humanity of the patients and the health care team trying to save them. 11/16/2018
Direct-to-consumer genetic testing kits are more popular than ever, but also come with caution from the clinical genetics community. VCU News spoke with Tahnee Causey, assistant director of the School of Medicine’s genetic counseling program, about genetic counseling and the popularity of direct-to-consumer testing kits. Read more »